NSAIDS
There is anecdotal evidence to suggest that NSAIDs could potentially harm patients infected with<unk> .
Some experts suggest avoiding NSAIDs altogether while recommending the use of paracetamol/acetaminophen instead.  
It is important to note that there is no strong evidence to suggest NSAIDs should be avoided in general in<unk>  patients
ACEi/ARBs
There is an increase in mortality in patients with both hypertension and<unk>  infection. 
ACEi and ARBs, used in the treatment of hypertension, has been postulated to contribute to the increased mortality by upregulating membrane-bound angiotensin-converting enzyme 2 (ACE2) which allows<unk>  entry into human cells. 
Currently, however, there is insufficient evidence to recommend against using ACEi and ARBs in patients with<unk> . 
Nebulizers
Avoid nebulizers as they are generally ineffective and may aerosolize virus
Albuterol with spacer is safer, though probably ineffective unless co-occuring reactive airway disease
MDI equivalents: Albuterol or ipratropium
<20 kg or 5yrs old: 4-5 puffs with a spacer every 20 minutes. 4 breaths between puffs.
>20 kg or 5yrs old: 8-10 puffs with a spacer every 20 minutes. 4 breaths between puffs.
There is anecdotal evidence to suggest that NSAIDs could potentially harm patients infected with<unk> .
Some experts suggest avoiding NSAIDs altogether while recommending the use of paracetamol/acetaminophen instead.  
It is important to note that there is no strong evidence to suggest NSAIDs should be avoided in general in<unk>  patients
There is an increase in mortality in patients with both hypertension and<unk>  infection. 
ACEi and ARBs, used in the treatment of hypertension, has been postulated to contribute to the increased mortality by upregulating membrane-bound angiotensin-converting enzyme 2 (ACE2) which allows<unk>  entry into human cells. 
Currently, however, there is insufficient evidence to recommend against using ACEi and ARBs in patients with<unk> . 
Avoid nebulizers as they are generally ineffective and may aerosolize virus
Albuterol with spacer is safer, though probably ineffective unless co-occuring reactive airway disease
MDI equivalents: Albuterol or ipratropium
<20 kg or 5yrs old: 4-5 puffs with a spacer every 20 minutes. 4 breaths between puffs.
>20 kg or 5yrs old: 8-10 puffs with a spacer every 20 minutes. 4 breaths between puffs.
MDI equivalents: Albuterol or ipratropium
<20 kg or 5yrs old: 4-5 puffs with a spacer every 20 minutes. 4 breaths between puffs.
>20 kg or 5yrs old: 8-10 puffs with a spacer every 20 minutes. 4 breaths between puffs.
<20 kg or 5yrs old: 4-5 puffs with a spacer every 20 minutes. 4 breaths between puffs.
>20 kg or 5yrs old: 8-10 puffs with a spacer every 20 minutes. 4 breaths between puffs.
COVID-19
Influenza
Rubella
URI
Anthrax
Pneumonia
H1N1 
Sinusitis